SCM Lifescience Statistics

Total Valuation

SCM Lifescience has a market cap or net worth of KRW 25.23 billion. The enterprise value is 29.37 billion.

Market Cap	25.23B
Enterprise Value	29.37B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

SCM Lifescience has 28.73 million shares outstanding. The number of shares has increased by 20.45% in one year.

Current Share Class	28.73M
Shares Outstanding	28.73M
Shares Change (YoY)	+20.45%
Shares Change (QoQ)	+34.56%
Owned by Insiders (%)	12.13%
Owned by Institutions (%)	n/a
Float	25.25M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	21.54
PB Ratio	1.22
P/TBV Ratio	1.27
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-2.74
EV / Sales	25.08
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-1.68

Financial Position

The company has a current ratio of 0.78, with a Debt / Equity ratio of 0.33.

Current Ratio	0.78
Quick Ratio	0.60
Debt / Equity	0.33
Debt / EBITDA	n/a
Debt / FCF	-0.39
Interest Coverage	-33.05

Financial Efficiency

Return on equity (ROE) is -56.38% and return on invested capital (ROIC) is -24.57%.

Return on Equity (ROE)	-56.38%
Return on Assets (ROA)	-23.12%
Return on Invested Capital (ROIC)	-24.57%
Return on Capital Employed (ROCE)	-40.04%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.05
Inventory Turnover	1.89

Taxes

Income Tax	-661.37M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -71.98% in the last 52 weeks. The beta is 1.07, so SCM Lifescience's price volatility has been similar to the market average.

Beta (5Y)	1.07
52-Week Price Change	-71.98%
50-Day Moving Average	930.66
200-Day Moving Average	1,592.37
Relative Strength Index (RSI)	48.62
Average Volume (20 Days)	235,712

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SCM Lifescience had revenue of KRW 1.17 billion and -10.70 billion in losses. Loss per share was -480.49.

Revenue	1.17B
Gross Profit	408.83M
Operating Income	-9.56B
Pretax Income	-11.37B
Net Income	-10.70B
EBITDA	-8.69B
EBIT	-9.56B
Loss Per Share	-480.49

Full Income Statement

Balance Sheet

The company has 2.71 billion in cash and 6.86 billion in debt, giving a net cash position of -4.14 billion or -144.17 per share.

Cash & Cash Equivalents	2.71B
Total Debt	6.86B
Net Cash	-4.14B
Net Cash Per Share	-144.17
Equity (Book Value)	20.62B
Book Value Per Share	743.43
Working Capital	-1.22B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -9.34 billion and capital expenditures -8.10 billion, giving a free cash flow of -17.44 billion.

Operating Cash Flow	-9.34B
Capital Expenditures	-8.10B
Free Cash Flow	-17.44B
FCF Per Share	-606.97

Full Cash Flow Statement

Margins

Gross Margin	34.92%
Operating Margin	-816.14%
Pretax Margin	-970.66%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SCM Lifescience does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-20.45%
Shareholder Yield	n/a
Earnings Yield	-42.43%
FCF Yield	-69.13%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on September 15, 2023. It was a forward split with a ratio of 1.2.

Last Split Date	Sep 15, 2023
Split Type	Forward
Split Ratio	1.2

Scores

SCM Lifescience has an Altman Z-Score of -6.87 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.87
Piotroski F-Score	3